Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Nearly Half Of Rheumatoid Arthritis Sufferers Feel Early Treatment Would Have Given Them More Independence
A UK survey of 575 rheumatoid arthritis sufferers highlights the importance of maintaining independence and the significant impact that early diagnosis and treatment can have. Over 94% of those surveyed claimed that their independence was compromised in some way, with over 60% saying it was compromised significantly. With earlier treatment of their disease, nearly half of the respondents felt that they would have been more independent today, making it vital that people are aware of the significance of early intervention.
generic viagra online
Testosterone Replacement For Men With Low Testosterone Improves Liver Function, Metabolic Syndrome
In middle-aged and older men with low testosterone levels, long-term testosterone replacement therapy greatly improves their fatty liver disease and their risk factors for cardiovascular disease and diabetes, a new study found. The results were presented at The Endocrine Society"s 91st Annual Meeting in Washington, D.C.
News of the day
Costliest Medicare Markets In Florida, New York, California
U.S. News & World Report examines cost, frequency, and outcomes studies on Medicare patients from the Dartmouth Institute for Health Policy and Clinical Practice : "The Dartmouth research is particularly relevant to older Americans because it is based to a large extent on Medicare data, involving patients ages 65 and older. The 2008 atlas, in particular, paints a devastating portrait of Medicare treatments based on an extensive study of Medicare recipients who died from one or more of nine chronic illnesses. Not only are chronic illnesses very expensive to treat, but they"re also the cause of most deaths in the United States. According to the 2008 atlas: More than 90 million Americans live with at least one chronic illness, and 7 out of 10 Americans die from chronic disease. Among the population that receives Medicare, the toll is even greater: About 9 out of 10 deaths are associated with just nine chronic illnesses: congestive heart failure, chronic lung disease, cancer, coronary artery disease, renal failure, peripheral vascular disease, diabetes, chronic liver disease, and dementia."
Public Health

XClinical To Present End-to-End Clinical Process

XClinical, a European vendor of innovative software products for eClinical trials, is presenting CDISC based tools for an End-To-End clinical process at the 45th DIA Annual Meeting in San Diego, USA. At the Annual Meeting "Better Medicines: Improving Safety with Every Step", taking place in San Diego on June 21st to June 25th 2009, the Drug Information Association is providing a meeting area for more than 8,900 professionals from over 800 exhibiting companies and more than 50 countries. 350 speaking sessions and three mega tracks are dealing with topics related to medical communications, clinical research and information technology. In addition to XClinical"s participation as exhibitor, Dr. Claus Lindenau, Head of Business Development, is going to be speaker at the session "CDISC SDTM Data Conversion: Reusability and Repeatability". The presentation will review the typical data transformation process to obtain CDISC SDTM and will compare advantages and disadvantages of using SAS code versus tools that use the CDISC XML based metadata. "Using tools that automatically generate mapping rules can speed up the process of validation since the generic mechanism of automatic rule generation needs to be validated only once and does not need to be completely repeated for every single trial." Said Dr. Lindenau. "Those mechanisms help to reduce costs and to avoid time delays, which you"re facing using SAS programs to transform data from clinical trials to CDISC SDTM." To get an insight on the standardization of the data transformation process, attend one of XClinical"s presentations of CDISC based tools for an End-To-End clinical process at booth # 1426. XClinical


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009